THE COST OF RELAPSE REMITTING MULTIPLE SCLEROSIS DISEASE - PATIENT REPORTED STUDY IN EGYPT

Author(s)

Anan I1, Abdel-Monem R1, Sharabi M2, Sharawy M2
1Accsight, Cairo, Egypt, 2MS care, Cairo, Egypt

Presentation Documents

OBJECTIVES: All Neurological disorders prevalence in Egypt is estimated to be 3.4% (El-Tallawy H 2013) Multiple Sclerosis (MS) represents 1.4% out of all neurological disorders in Egypt (Hashem S. et al 2010) thus 59,671 patients from all population of 2015 (92M), out of which 73% are Relapse Remitting MS This Patient reported self-administered study aims to assess the Economic Burden caused by RRMS on Egyptian patients. METHODS:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PND24

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Neurological Disorders

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×